Business Context and Reporting Period
Company: IRADIMED CORP (IRMD)
Filing Type: Form 8-K (Current Report)
Date of Report: February 6, 2020
Reporting Period: Fourth quarter ended December 31, 2019
Context: The filing serves to announce the issuance of a press release containing financial results for the fourth quarter of 2019.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific financial data. It references a press release (Exhibit 99.1) for details on revenue, profit, cash flow, margins, debt, and liquidity. Consequently, the filing text does not provide a clear value for any specific financial metric.
Material Changes
No material changes or comparative financial data are disclosed within the text of this filing. The document solely indicates that results for the period were announced via a separate press release.
Guidance, Outlook, and Risks
Management Commentary: The filing notes the issuance of a press release regarding Q4 2019 results but does not include the content of that commentary.
Legal Disclaimer: The information in Item 2.02 and Exhibit 99.1 is not deemed "filed" under Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Risks and Contingencies: No specific risks or contingencies are detailed in this text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated February 6, 2020) for actual Q4 2019 revenue, earnings, and cash flow figures.
- Verify the company's status as an emerging growth company (indicated as checked in the filing).
- Confirm the trading symbol (IRMD) and exchange (NASDAQ Capital Market) for current market data.
- Check subsequent filings for the full 10-K to obtain audited financial statements for the year ended December 31, 2019.